MKI67 and breast carcinoma: Similar with the results from in vitro experiments, Dox treatment suppressed the in vivo growth of breast cancer cells and the tumor size, which was enhanced by combination with CYT (Figures 3A,B), simultaneously suppressed the KI-67 level (Figure 3C).